- Vibha C.A. Desai, Yann Ferrand, Teresa M.
Cavanaugh, C.M.L. Kelton, Jaime J. Caro, Jens Goebel, and Pamela C. Heaton
(2017), "Comparative Effectiveness of Tacrolimus-Based Steroid Sparing
versus Steroid Maintenance Regimens in Kidney Transplantation: Results from
Discrete Event Simulation," Medical Decision Making, 37(7):
827-843.
- Jeffrey A. Thompson, Pamela C. Heaton, C.M.L. Kelton, and
Thomas J. Sitzman (2017), "National Estimates of and Risk Factors for
Inpatient Revision Surgeries for Orofacial Clefts," The
Cleft Palate-Craniofacial Journal, 54(1): 60-69.
- Ying Xia, C.M.L. Kelton, Patricia R. Wigle,
Pamela C. Heaton, and Jeff J. Guo (2016), "Twenty Years of Triptans in the
United States Medicaid Programs: Utilization and Reimbursement Trends
from 1993-2013," Cephalalgia, 36(14): 1305-1315.
- Pamela C. Heaton, Vibha C.A. Desai, C.M.L. Kelton, and
Swapnil N. Rajpathak (2015), "Sulfonylurea Use and the Risk of Hospital
Readmission in Patients with Type 2 Diabetes, BMC Endocrine Disorders
16:4.
DOI: 10.1186/s12902-016-0084-z. Available at
http://www.biomedcentral.com/1472-6823/16/4.
- Ying Xia, C.M.L. Kelton, Jeff J. Guo,
Boyang Bian, and Pamela C. Heaton (2015), "Treatment of Obesity:
Pharmacotherapy Trends in the United States fromf 1999 to 2010," Obesity,
23(8): 1721-1728.
- Vibha C.A. Desai, C.M.L. Kelton, Anne H. Metzger,
Teresa M. Cavanaugh, Jeff J. Guo, and Pamela C. Heaton (2014), "Comparative
Persistence on b-Blockers versus
Calcium Channel Blockers for Ventricular Rate Control in Nonelderly Patients
with Atrial Fibrillation," Annals of Pharmacotherapy, 48(12):
1570-1579.
- Amarsinh M. Desai, Teresa M. Cavanaugh, Vibha C.A.
Desai, Pamela C. Heaton, and C.M.L. Kelton (2014), "Trends in the Outpatient
Treatment of Atrial Fibrillation in the United States from 2001 to 2010,"
Pharmacoepidemiology and Drug Safety, 23(5): 539-547.
- C.M.L. Kelton, Lenisa V. Chang, Jeff J. Guo, Yan
Yu, Edmund A. Berry, Boyang Bian, and Pamela C. Heaton (2014), "Firm- and
Drug-Specific Patterns of Generic Drug Payments by U.S. Medicaid Programs:
1991-2008," Applied Health Economics and Health Policy, 12(2):
165-177.
- Ying Xia, C.M.L. Kelton, Liang Xue, Jeff J. Guo,
Boyang Bian, and Patricia R. Wigle (2013), "Safety of Long-Acting Beta
Agonists and Inhaled Corticosteroids in Children and Adolescents with
Asthma," Therapeutic Advances in Drug Safety, 4(6): 254-263.
- Vibha C.A. Desai, C.M.L. Kelton, Richard J. Czosek, and Pamela C. Heaton
(2013), "Frequencies, Costs, and Complications of Catheter Ablation for
Tachyarrhythmias in Children: 2000-2009," Pacing and Clinical
Electrophysiology, 36(12): 1468-1480.
- C.M.L. Kelton, Lenisa V. Chang, and David H. Kreling (2013), "State Medicaid
Programs Missed $220 Million in Uncaptured Savings as Generic Fluoxetine Came to
Market, 2001-05," Health Affairs 32: 1204-1211.
- Namita L. Tundia, C.M.L. Kelton, Teresa M.
Cavanaugh, Jeff J. Guo, Dennis J. Hanseman, and Pamela C. Heaton (2013),
"The Effect of Electronic Medical Record System Sophistication on Preventive
Healthcare for Women," Journal of the American Medical
Informatics Association, 20(2): 268-276.
- Edmund A. Berry,
C.M.L. Kelton, Jeff J. Guo, and
Pamela C. Heaton (2013), "Adaptation and Application of the Agency for
Healthcare Research and Quality’s Asthma-Admission-Rate Pediatric Quality
Indicator to Ohio Medicaid Claims Data," Research in Social and Administrative Pharmacy,
9(3): 240-250.
- Ziyad S. Almalki, Abdullah K. Alahmari, Jeff J. Guo,
and C.M.L. Kelton (2012), "Access to Orphan Drugs in the Middle East:
Challenge and Perspective," Intractable & Rare Diseases
Research, 1(4): 139-143.
- Jeff J. Guo, Jasmanda Wu, C.M.L. Kelton, Yonghua Jing,
Huihao Fan, Paul E. Keck Jr., Nick C. Patel (2012), "Exposure
to Potentially Dangerous Drug-Drug Interactions Involving Antipsychotics,"
Psychiatric Services, 63(11):1080-1088.
- Vibha C.A. Desai, Teresa M. Cavanaugh, C.M.L. Kelton, Jeff J. Guo, and
Pamela C. Heaton (2012), "Trends in the Utilization of, Spending on, and
Prices for Outpatient Antifungal Agents in U.S. Medicaid Programs," Clinical Therapeutics,
34(10): 2118-2131.e1.
- Boyang Bian, Elizabeth Gorevski, C.M.L. Kelton, Jeff J. Guo, and Jill E.
Martin-Boone (2012), "Long-Term Medicaid Excess Payments from Alleged Price
Manipulation of Generic Lorazepam," Journal of Managed Care Pharmacy, 18(7):
506-515.
- Jing Guo, C.M.L. Kelton, and Jeff J. Guo (2012), "Recent
Developments, Utilization and Spending Trends for Pompe Disease Therapies,"
American Health & Drug Benefits, 5(3): 182-188.
-
Vibha C.A. Desai, Pamela C. Heaton, and
C.M.L. Kelton (2012), "Impact of the FDA's Antipsychotic Black-Box Warning
on Psychotropic Drug Prescribing in Elderly Patients with Dementia in
Outpatient and Office-Based Settings," Alzheimer's &
Dementia, 8(5): 453-457.
-
Pamela C. Heaton, Namita L. Tundia, Nicole Schmidt, Patricia R. Wigle, and
C.M.L. Kelton (2012), "The National Burden of Pediatric Hospitalizations for
Inflammatory Bowel Disease: Results from the 2006 Kids' Inpatient
Database," Journal of Pediatric Gastroenterology and
Nutrition, 54(4): 477-485.
-
Elizabeth
Gorevski, Boyang Bian, C.M.L.
Kelton, Jeff J. Guo, Jill E. Martin-Boone (2012), “Utilization,
Spending, and Price Trends for Benzodiazepines in the U.S. Medicaid Program:
1991-2009,” Annals of
Pharmacotherapy, 46: 503-512.
-
Elizabeth Gorevski, Boyang Bian, C.M.L.
Kelton, Jill E. Martin-Boone, and Jeff J. Guo (2012), "Evidence-Based
Prediction of Statin Utilization with Lipid-Panel Data from the National
Health and Nutrition Examination Survey," Value in Health, 15(1):
32-38.
-
Edmund A. Berry, Pamela C. Heaton, and C.M.L. Kelton (2011), "National
Estimates of the Inpatient Burden of Pediatric Bipolar Disorder in the
United States," The Journal of
Mental Health Policy and Economics, 14(3): 115-123.
-
Namita L. Tundia, Pamela C. Heaton, and
C.M.L. Kelton (2011), "The National Burden of E-Code-identified Adverse Drug
Events Among Hospitalized Children Using a National Discharge Database,"
Pharmacoepidemiology and Drug Safety, 20: 866-878.
-
Shih-Feng Chiu, C.M.L. Kelton, Jeff J. Guo,
Patricia R. Wigle, Alex C. Lin, and Sheryl L. Szeinbach (2011),
"Utilization, Spending, and Price Trends for Long-Acting Beta Agonists and
Inhaled Corticosteroids in the U.S. Medicaid Program from 1991 to 2010,"
American Health & Drug Benefits, 4(3): 140-149.
-
Jeff J. Guo, Katherine Tsai, C.M.L. Kelton,
Boyang Bian, and Patricia R. Wigle (2011), "Risk
of Serious Asthma Exacerbations Associated with Long-Acting Beta Agonists
among Patients with Asthma: A Retrospective Cohort Study," Annals of Allergy, Asthma & Immunology,
106(3): 214-222.e2.
-
Yann Ferrand,
C.M.L. Kelton, Jeff J. Guo, Martin S. Levy, and Yan Yu (2011), "Using
Time-Series Intervention Analysis to Understand U.S. Medicaid Expenditures
on Antidepressant Agents," Research in Social and
Administrative Pharmacy, 7(1): 64-80.
-
Yan-Jun
Zhang, Jeff J. Guo, and
C.M.L. Kelton (2011), “Cost Consequence of Colcrys is Not That
Astounding,” on-line rapid response in the
British Medical Journal.
January 3, 2011. Available at
http://www.bmj.com/content/341/bmj.c6459.full/reply#bmj_el_245683.
-
Boyang Bian,
C.M.L. Kelton, Jeff J. Guo, and Patricia R. Wigle (2010), "Ace Inhibitor and
ARB Utilization and Expenditures in the Medicaid Fee-For-Service Program
from 1991 to 2008." Journal of Managed Care Pharmacy, 16(9):
671-679.
-
Boyang Bian,
C.M.L. Kelton, Patricia R. Wigle, and Jeff J. Guo (2010),
"Evaluating Safety of Long-Acting Beta Agonists (LABAs) in Patients with
Asthma," Current Drug Safety, 5(3): 245-250.
-
C.M.L. Kelton
and Margaret K. Pasquale (2009), "Evaluating the Claim of Enhanced
Persistence: The Case of Osteoporosis and Implications for Payers,"
Medical Decision Making, 29(6): 690-706.
-
Jeffery A. Demland, Yonghua Jing, C.M.L.
Kelton, Jeff J. Guo, Hong Li, and Patricia R. Wigle (2009), "Drug Use
Pattern and Off-Label Use of Atypical Antipsychotics Among Adult Patients
with Bipolar Disorder: 1998-2002," American Health & Drug
Benefits, 2(4): 184-191.
-
Yann Ferrand, C.M.L. Kelton, Ke Chen, and Howard A.
Stafford (2009), "Biotechnology in Cincinnati: Clustering or Colocation?,"
Economic Development Quarterly, 23(2): 127-140.
-
Jeff J. Guo and C.M.L. Kelton (2009), "The Role of
Epidemiology in New Drug Development," American Health &
Drug Benefits, 2(1) Supplement: S49-S54.
-
Jeff J. Guo, Yonghua Jing, Kiet Nguyen, Huihao Fan,
Xing Li, and C.M.L. Kelton (2008), "Principal Components Analysis of Drug
Expenditure and Utilization Trends for Major Therapeutic Classes in U.S.
Medicaid Programs," Journal of Medical Economics, 11(4):
671-694.
-
Yan Chen, C.M.L. Kelton, Yonghua Jing, Jeff J. Guo,
Xing Li, and Nick C. Patel (2008), "Utilization, Price, and Spending Trends
for Antidepressants in the U.S. Medicaid Program," Research in Social and Administrative Pharmacy,
4: 244-257.
-
Jeff J. Guo, Paul E. Keck, Hong Li, Ray Jang, and
C.M.L. Kelton (2008), "Treatment Costs and Health Care Utilization for
Patients with Bipolar Disorder in a Large Managed Care Population,'' Value in Health,
11(3): 416-423.
- C.M.L. Kelton, Robert P. Rebelein,
Pamela C. Heaton, Yann Ferrand, and Jeff J. Guo (2008), “Differences in the
Cost of Antidepressants Across State Medicaid Programs,” The Journal of Mental Health Policy
and Economics, 11(1): 33-47.
- Wenmin Du, Yonghua Jing, C.M.L. Kelton, and Jeff J.
Guo (2008), "Drug Safety Surveillance in China and Other Countries: A Review
and Comparison,'' Value in Health, 11 Supplement 1: S130-S136.
- C.M.L. Kelton, Margaret K. Pasquale, and
Robert P. Rebelein
(2008), “Using NAICS to Identify National Industry Cluster Templates for Applied
Regional Analysis,” Regional Studies, 42(3): 305-321.
- C.M.L. Kelton, Robert P. Rebelein,
Michelle L. Dusing, Yann Ferrand, and Jeff J. Guo (2007), “Analysis of
Pharmaceutical Products with Large Price Changes in a Regional Hospital
System,” Journal of Pharmaceutical
Finance, Economics and Policy; 16(2): 61-86.
- Yonghua Jing, Patricia Klein, C.M.L. Kelton, Xing Li,
and Jeff J. Guo (2007), "Utilization and Spending Trends for
Antiretroviral Medications in the U.S. Medicaid Program from 1991 to 2005,"
AIDS Research and Therapy 4:22, available at
http://www.aidsrestherapy.com/content/4/1/22.
- Jeff J. Guo and C.M.L. Kelton (2007), “Competition:
Brand-Name versus Generic Drugs," in Handbook of Pharmaceutical
Public Policy, eds. Thomas R. Fulda and Albert I. Wertheimer, Chapter 20,
pp. 395-416, Haworth Press, Inc., New York.
- Yonghua Jing, C.M.L. Kelton, Xing Li, and Jeff J. Guo
(2007),``Lethal Drug Probe in China: The Case of Xinfu Clindamycin,'' Pharmacoepidemiology and Drug Safety
16, 928-932.
- C.M.L. Kelton and Robert P. Rebelein
(2007), “Can We Have a High-End Retail Department Store?,” Economic Development
Journal; 6(1):22-29.
- C.M.L. Kelton and Robert P. Rebelein (2007), “A
General-Equilibrium Analysis of Public Policy for Pharmaceutical Prices,” Journal of Public Economic Theory; 9(2):285-318.
- Yonghua Jing, C.M.L. Kelton, Jeff J.
Guo, Huihao Fan, Yan Chen, Xing Li, and Nick C. Patel (2007), “Price, Utilization, and Spending for Antipsychotic
Medications in the Medicaid Program,” Drug Benefit Trends; 19(1):27-41.
- Yonghua Jing, C.M.L. Kelton, Jeff J.
Guo, Yan Chen, Xing Li, and
Patricia R. Wigle (2006), “Price and Utilization of Statins in the Medicaid Program,”
Drug Benefit Trends; 18(11):580-592.
- C.M.L. Kelton,
Jeffrey Rexhausen, and George Vredeveld (2006), “The Spatial Distribution of Chemical Production in
the USA.” Regions & Locations Guide 01/2006: 44-46.
- C.M.L. Kelton, Margaret K.
Pasquale, and Miriam Levitt (2006), “Barriers to SCHIP Enrollment: A
Statistical Cross-County Study for the State of Pennsylvania,” Politics
and the Life Sciences 24(1-2), 22-31.
- Michelle L. Dusing, Jeff. J. Guo, C.M.L. Kelton, and Margaret K. Pasquale,
(2005), “Competition and
Price Discounts for a Hospital Buyer in the Anti-Infective Pharmaceutical
Market,”
Journal of Pharmaceutical Finance,
Economics, and Policy 14(2), 59-85.
- Jeff. J. Guo, C.M.L. Kelton, Margaret K. Pasquale,
Jennie Zimmerman, Amit Patel, Pamela C. Heaton, and Robert J. Cluxton (2004),
“Price and Market-Share
Competition of Firms Selling Anti-Ulcer Gastric Medications in the Ohio
Medicaid Market,”
International Journal of
Pharmaceutical Medicine 18(5), 271-282.
- Elizabeth M. Caucutt, Mrinal Ghosh, and C.M.L. Kelton (1999),
“Durability
Versus Concentration as an Explanation for Price Inflexibility,” Review of
Industrial Organization 14, 27-50.
- Elizabeth M. Caucutt, Mrinal Ghosh, and C.M.L. Kelton (1998),``Robustness
of the Relationship Between Price Variability and Inflation for United
States Manufacturing,'' Applied Economics 30, 513-519.
- C.M.L. Kelton and Linda G. Schneider Stone (1998),
“Optimal Television
Schedules in Alternative Competitive Environments,”
European Journal of
Operational Research 104, 451-473.
- Elizabeth M. Caucutt, Mrinal Ghosh, and C.M.L. Kelton (1994), “Pricing
Behavior in United States Manufacturing Industries: A Statistical Study Using
Disaggregated Data,” Review of Industrial Organization 9,
745-771.
- C.M.L. Kelton (1994), ``Entry and Exit in
Markov-Process Models Estimated from Macro Data, with Applications to Shifts
Between Advertising Media,'' Journal of Statistical Computation and
Simulation 50, 213-233.
- C.M.L. Kelton and W. David Kelton (1993),
``Closure-State Specification for Markov-Process Models with Incomplete
Micro Data,'' Journal of Statistical Computation and Simulation 47,
195-217.
- C.M.L. Kelton (1992), ``Price Changes from
1958--1982,'' in Empirical Studies in Industrial Organization, eds.
David Audretsch and John J. Siegfried, 97-114, Kluwer Academic Publishers,
Amsterdam.
- C.M.L. Kelton and W. David Kelton (1991), ``A
Comparison of Micro versus Macro Point Estimators for Markov-Process
Models,'' Journal of Statistical Computation and Simulation, 38,
201-210.
- C.M.L. Kelton and Marlene A. Smith (1991),
``Statistical Inference in Nonstationary Markov Process Models with Embedded
Explanatory Variables,'' Journal of Statistical Computation and
Simulation, 38, 25--44.
- C.M.L. Kelton and Leonard W. Weiss (1989), “Change in Price, Change in
Cost, Change in Demand, and Change in Concentration” in Concentration and
Price, edited by Leonard W. Weiss, 41-66, M.I.T. Press, Cambridge, Mass.
- C.M.L. Kelton and Marlene A. Smith (1987),
``Estimation Efficiency for Markov Chain Models,'' Journal of Statistical
Computation and Simulation, 28, 145-165.
- C.M.L. Kelton (1985), “Earnings Behavior in Food and Tobacco
Manufacturing,” Review of Industrial Organization 2, 266-291.
- C.M.L. Kelton and W. David Kelton (1987),
``Comparison of Hypothesis Testing Techniques for Markov Processes Estimated
from Micro vs. Macro Data,'' The Annals of Operations Research, 8,
175-194.
- C.M.L. Kelton and Marlene A. Smith (1986),
``Nonlinear Programming Solutions to the Nonstationary Markov Model,'' Communications in Statistics: Simulation and Computation, 15,
1169--1190.
- C.M.L. Kelton (1986), ``The Inflationary Contribution
of Market Structure in Food and Tobacco Manufacturing,'' in Issues After
a Century of Federal Competition Policy, eds. Robert L. Wills, Julie A.
Caswell, and John D. Culbertson, 345-359, Lexington Books, Lexington, Mass.
- C.M.L. Kelton (1985), ``Earnings Behavior in Food and
Tobacco Manufacturing,'' Review of Industrial Organization, 2,
266-291.
- C.M.L. Kelton and W. David Kelton (1985),
``Development of Specific Hypothesis Tests for Estimated Markov Chains,'' Journal
of Statistical Computation and Simulation, 23, 15-39.
- C.M.L. Kelton (1984), ``Nonstationary Markov
Modeling: An Application to Wage-Influenced Industrial Relocation,'' International Regional Science Review, 9, 75-90.
- C.M.L. Kelton and W. David Kelton (1984), ``Markov
Process Models: A General Framework for Estimation and Inference in the
Absence of State Transition Data,'' in Mathematical Modelling in Science
and Technology, the Fourth International Conference, Zurich, eds. X.J.R.
Avula, R.E. Kalman, A.I. Liapis, and E.Y. Rodin, 299-304, Pergamon Press,
Oxford.
- W. David Kelton and C.M.L. Kelton (1984),
``Hypothesis Tests for Markov Process Models Estimated from Aggregate
Frequency Data,'' Journal of the American Statistical Association,
79, 922-928.
- C.M.L. Kelton (1983), Trends in the Relocation of
U.S. Manufacturing, UMI Research Press, Ann Arbor, Michigan.
- C.M.L. Kelton (1983)``The Effect of Advertising on
Price Change for Food Manufacturing Product Classes,'' in Advertising and
the Food System, eds. J.M. Connor and R.W. Ward, 257-273, North Central
Regional Research Project NC117 Monograph No. 14, Madison, Wisconsin.
- C.M.L. Kelton and W. David Kelton (1982), “Advertising and Intraindustry
Brand Shift in the U.S. Brewing Industry,” The Journal of Industrial
Economics 30, 293-303.
- C.M.L. Kelton (1981), ``Estimation of
Time-Independent Markov Processes with Aggregate Data: A Comparison of
Techniques,'' Econometrica, 49, 517-518.
